BACE1

BACE1 (Beta-Secretasa 1) plays a crucial role in the pathological process that leads to the formation of beta-amyloid plaques, a hallmark of Alzheimer’s disease. These plaques are abnormal protein accumulations that interfere with communication between neurons and contribute to their progressive deterioration. BACE1 research using AI focuses on accelerating drug discovery by modeling molecular interactions and identifying effective inhibitors. This innovative approach integrates computational tools with biology, paving the way for advanced Alzheimer’s therapies. The medical application of AI is a breakthrough, AI is able to accelerate the most complex study processes, investigating with greater precision for each specific use case.